The North America Remote Patient Monitoring Market was valued at USD 10.2 billion in 2024 and is estimated to grow at a CAGR of 10.6% to reach USD 27.5 billion by 2034.
Demand for remote patient monitoring (RPM) solutions continues to rise due to the growing burden of chronic illnesses, rapid advancements in digital health technologies, and the ongoing shift toward value-based healthcare. Patients and clinicians are increasingly adopting connected, intuitive, and accurate RPM tools, including wearable sensors, digital health apps, and cloud-based platforms to support continuous monitoring outside traditional clinical environments. Adoption is further boosted by strong reimbursement policies, well-established healthcare systems, and the expanding elderly population across the region. Federal initiatives and government-led digital health programs play a pivotal role in accelerating RPM deployment. Expanded reimbursement from the Centers for Medicare & Medicaid Services (CMS) has encouraged healthcare providers to integrate remote monitoring into chronic care workflows. Combined with rising awareness and widespread access to connected technologies, these factors continue to drive significant growth in wearable sensors, mobile platforms, and cloud-integrated monitoring systems throughout North America.
In 2024, the cardiac monitoring devices segment accounted for a 19.6% share and is expected to reach USD 5.7 billion by 2034, growing at a CAGR of 11.2%. This category remains essential within the RPM landscape as cardiovascular conditions require ongoing, precise monitoring. These systems track critical cardiac indicators, including rhythm irregularities, heart rate behavior, and related markers that support earlier detection and faster clinical responses. They have become an integral solution for patients managing long-term heart conditions or those undergoing post-procedural recovery.
The diabetes segment captured a 56.3% share in 2024, supported by the increasing number of individuals diagnosed with diabetes and the continued shift toward real-time disease management. Continuous glucose monitoring devices are widely preferred since they help patients check glucose fluctuations, manage insulin needs, and monitor metabolic patterns without repeated clinic visits. With seamless integration into digital care platforms, such systems enable patients and providers to share real-time updates, improving adherence and facilitating timely clinical adjustments.
U.S. Remote Patient Monitoring Market held a significant share in 2024, owing to its large chronic disease population, advanced digital health infrastructure, and strong regulatory backing. The country’s diverse patient base sustains steady usage of RPM technologies across multiple demographics. As home-based care becomes more prominent, individuals increasingly favor smart monitoring tools such as connected blood pressure systems, wearable ECG devices, and digital pulse oximeters rather than frequent office appointments. These technologies support continuous data transmission, enabling clinicians to make quick, informed decisions while helping reduce emergency visits and hospital readmissions.
Key companies active in the North America Remote Patient Monitoring Market include Medtronic, Abbott Laboratories, Dexcom, Johnson & Johnson, GE Healthcare, OMRON Healthcare, Baxter International, BIOTRONIK SE & Co. KG, Koninklijke Philips N.V., Boston Scientific, F. Hoffmann-La Roche Ltd, Sotera Wireless, and VitalConnect. Companies in the North America Remote Patient Monitoring Market strengthen their positions by expanding AI-enabled monitoring platforms, enhancing device connectivity, and integrating cloud-based analytics to deliver real-time insights. Many firms collaborate with healthcare providers, insurers, and digital health networks to improve care coordination and expand reimbursement coverage. Investments in data security, interoperability, and multi-parameter monitoring capabilities also play a major role in building trust and improving adoption. Partnerships with telehealth companies, acquisitions of digital health startups, and continuous product innovation, such as advanced wearables and long-term biosensors, help organizations scale their presence, meet regulatory standards, and address the rising demand for home-based healthcare solutions.
This product will be delivered within 2-4 business days.
Demand for remote patient monitoring (RPM) solutions continues to rise due to the growing burden of chronic illnesses, rapid advancements in digital health technologies, and the ongoing shift toward value-based healthcare. Patients and clinicians are increasingly adopting connected, intuitive, and accurate RPM tools, including wearable sensors, digital health apps, and cloud-based platforms to support continuous monitoring outside traditional clinical environments. Adoption is further boosted by strong reimbursement policies, well-established healthcare systems, and the expanding elderly population across the region. Federal initiatives and government-led digital health programs play a pivotal role in accelerating RPM deployment. Expanded reimbursement from the Centers for Medicare & Medicaid Services (CMS) has encouraged healthcare providers to integrate remote monitoring into chronic care workflows. Combined with rising awareness and widespread access to connected technologies, these factors continue to drive significant growth in wearable sensors, mobile platforms, and cloud-integrated monitoring systems throughout North America.
In 2024, the cardiac monitoring devices segment accounted for a 19.6% share and is expected to reach USD 5.7 billion by 2034, growing at a CAGR of 11.2%. This category remains essential within the RPM landscape as cardiovascular conditions require ongoing, precise monitoring. These systems track critical cardiac indicators, including rhythm irregularities, heart rate behavior, and related markers that support earlier detection and faster clinical responses. They have become an integral solution for patients managing long-term heart conditions or those undergoing post-procedural recovery.
The diabetes segment captured a 56.3% share in 2024, supported by the increasing number of individuals diagnosed with diabetes and the continued shift toward real-time disease management. Continuous glucose monitoring devices are widely preferred since they help patients check glucose fluctuations, manage insulin needs, and monitor metabolic patterns without repeated clinic visits. With seamless integration into digital care platforms, such systems enable patients and providers to share real-time updates, improving adherence and facilitating timely clinical adjustments.
U.S. Remote Patient Monitoring Market held a significant share in 2024, owing to its large chronic disease population, advanced digital health infrastructure, and strong regulatory backing. The country’s diverse patient base sustains steady usage of RPM technologies across multiple demographics. As home-based care becomes more prominent, individuals increasingly favor smart monitoring tools such as connected blood pressure systems, wearable ECG devices, and digital pulse oximeters rather than frequent office appointments. These technologies support continuous data transmission, enabling clinicians to make quick, informed decisions while helping reduce emergency visits and hospital readmissions.
Key companies active in the North America Remote Patient Monitoring Market include Medtronic, Abbott Laboratories, Dexcom, Johnson & Johnson, GE Healthcare, OMRON Healthcare, Baxter International, BIOTRONIK SE & Co. KG, Koninklijke Philips N.V., Boston Scientific, F. Hoffmann-La Roche Ltd, Sotera Wireless, and VitalConnect. Companies in the North America Remote Patient Monitoring Market strengthen their positions by expanding AI-enabled monitoring platforms, enhancing device connectivity, and integrating cloud-based analytics to deliver real-time insights. Many firms collaborate with healthcare providers, insurers, and digital health networks to improve care coordination and expand reimbursement coverage. Investments in data security, interoperability, and multi-parameter monitoring capabilities also play a major role in building trust and improving adoption. Partnerships with telehealth companies, acquisitions of digital health startups, and continuous product innovation, such as advanced wearables and long-term biosensors, help organizations scale their presence, meet regulatory standards, and address the rising demand for home-based healthcare solutions.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, by Product, 2021-2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Application, 2021-2034 ($ Mn)
Chapter 7 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Country, 2021-2034 ($ Mn)
Chapter 9 Company Profiles
Companies Mentioned
The companies profiled in this North America Remote Patient Monitoring market report include:- Abbott Laboratories
- Baxter International
- BIOTRONIK SE & Co. KG
- Boston Scientific
- Dexcom
- F. Hoffmann-La Roche Ltd
- GE Healthcare
- Johnson & Johnson
- Koninklijke Philips N.V.
- Medtronic
- OMRON Healthcare
- Sotera Wireless
- VitalConnect
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 90 |
| Published | December 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 10.2 Billion |
| Forecasted Market Value ( USD | $ 27.5 Billion |
| Compound Annual Growth Rate | 10.6% |
| Regions Covered | North America |
| No. of Companies Mentioned | 14 |
